Sinco Pharmaceuticals Holdings Limited

SEHK:6833 Rapport sur les actions

Capitalisation boursière : HK$382.2m

Sinco Pharmaceuticals Holdings Gestion

Gestion contrôle des critères 3/4

Le PDG Sinco Pharmaceuticals Holdings est Min Jin, nommé en Mar2023, a un mandat de 1.67 ans. La rémunération annuelle totale est CN¥ 1.96M, composée du salaire de 94.6% et des bonus 5.4%, y compris les actions et options de la société. détient directement 0.67% des actions de la société, d'une valeur de HK$ 2.57M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.8 ans et 6 ans.

Informations clés

Min Jin

Directeur général

CN¥2.0m

Rémunération totale

Pourcentage du salaire du PDG94.6%
Durée du mandat du directeur général1.7yrs
Propriété du PDG0.7%
Durée moyenne d'occupation des postes de direction1.8yrs
Durée moyenne du mandat des membres du conseil d'administration6yrs

Mises à jour récentes de la gestion

Recent updates

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Analyse de la rémunération des PDG

Comment la rémunération de Min Jin a-t-elle évolué par rapport aux bénéfices de Sinco Pharmaceuticals Holdings?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

CN¥47m

Mar 31 2024n/an/a

CN¥44m

Dec 31 2023CN¥2mCN¥2m

CN¥42m

Sep 30 2023n/an/a

CN¥35m

Jun 30 2023n/an/a

CN¥27m

Mar 31 2023n/an/a

CN¥48m

Dec 31 2022CN¥2mCN¥2m

CN¥69m

Rémunération vs marché: La rémunération totale de Min ($USD 272.91K ) est dans la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 236.00K ).

Rémunération et revenus: La rémunération de Min a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Min Jin (46 yo)

1.7yrs

Titularisation

CN¥1,959,000

Compensation

Mr. Min Jin is Chief Accountant since August 17, 2023 and Secretary since December 21, 2023 at Nanjing Tanker Corporation. He was Co-Chief Executive Officer at Sinco Pharmaceuticals Holdings Limited since...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Xiangbin Huang
Executive Chairman13.6yrsCN¥7.10m51.65%
HK$ 197.4m
Min Jin
Chief Executive Officer1.7yrsCN¥1.96m0.67%
HK$ 2.6m
Shifeng Lei
Executive Directorno dataCN¥1.09mpas de données
Yifan Li
Chief Financial Officer9.4yrspas de donnéespas de données
Zhijian Huang
Executive Directorless than a yearpas de donnéespas de données
Yunlu Peng
Company Secretary5.1yrspas de donnéespas de données
Tao Zhang
President of Sichuan Sinco Pharmaceuticals Co. Ltd.2yrspas de donnéespas de données

1.8yrs

Durée moyenne de l'emploi

44yo

Âge moyen

Gestion expérimentée: L'équipe de direction de 6833 n'est pas considérée comme expérimentée (ancienneté moyenne 1.8 ans), ce qui suggère une nouvelle équipe.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Xiangbin Huang
Executive Chairman13.6yrsCN¥7.10m51.65%
HK$ 197.4m
Shifeng Lei
Executive Director1.7yrsCN¥1.09mpas de données
Zhijian Huang
Executive Directorless than a yearpas de donnéespas de données
Ying Kit Lau
Independent Non-Executive Director6yrsCN¥300.00kpas de données
Wenfang Liu
Independent Non-Executive Director8.8yrsCN¥300.00kpas de données
Qing Wang
Independent Non-Executive Director8.8yrsCN¥300.00kpas de données
Zhizhong Bai
Independent Non-Executive Director4.2yrsCN¥300.00kpas de données

6.0yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 6833 sont considérés comme expérimentés (ancienneté moyenne 6 ans).